Company Overview of TNO Triskelion BV
TNO Triskelion BV operates as a contract research organization which offers analysis, toxicology, and chemical risk assessment services. It provides food mapping, nutrient analysis, and biomarker analysis services. The company is based in Zeist, the Netherlands. TNO Triskelion BV operates as a subsidiary of TNO.
Zeist, 3704 HE
Key Executives for TNO Triskelion BV
TNO Triskelion BV does not have any Key Executives recorded.
TNO Triskelion BV Key Developments
TNO Triskelion Introduced Bio Safety Level 3
Mar 3 14
TNO Triskelion announced introduction of a Bio Safety Level 3 (BSL-3) facility and development of special techniques allow to test vaccines against deadly viruses like avian flu and SARS. With this step the contract research organisation responds to a globally growing demand for testing facilities for the development of drugs against these dangerous infectious diseases. It also allows new vaccines against rapidly mutating (avian) influenza viruses reach the public sooner. TNO Triskelion performs research activities for the pharmaceutical, chemical and food industries. The TNO Triskelion facility was recently upgraded to BSL-3 level and accredited by Public Health England (PHE), so that all class 3 viruses and bacteria deadly to humans - from HIV to tuberculosis, from avian influenza to SARS - can be studied in conformity with Good Laboratory Practice (GLP) if required. On a worldwide scale the testing capacity for vaccines against these viruses is extremely limited. The BSL-3 facility will be used for research into avian flu. The Avian Influenza A Virus H7N9 recently appeared in China, taking 40 lives. Virus H5N1 has been active since 1997, H7N7 has made victims since 2008 and recently a woman in China died from H10N8. The viruses spread mostly from animals to man. If avian flu evolves into a virus that transmits from person to person, the threat of a worldwide pandemic is at hand.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries